Author/Authors
Baykara, Meltem Sakarya Üniversitesi - Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kliniği, Turkey , Algin, Efnan Gazi Üniversitesi - Tıp Fakültesi - Tıbbi Onkoloji Bilim Dalı, Turkey , Büyükberber, Süleyman Gazi Üniversitesi - Tıp Fakültesi - Tıbbi Onkoloji Bilim Dalı, Turkey , Tufan, Gülnihal Gazi Üniversitesi - Tıp Fakültesi - Tıbbi Onkoloji Bilim Dalı, Turkey , Cavnar, Burçak Gazi Üniversitesi - Tıp Fakültesi - İç Hastalıkları Anabilim Dalı, Turkey , Demirci, Umut Ankara Atatürk - Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kiniği, Turkey , Coşkun, Uğur Gazi Üniversitesi - Tıp Fakültesi - Tıbbi Onkoloji Bilim Dalı, Turkey , Benekli, Mustafa Gazi Üniversitesi - Tıp Fakültesi - Tıbbi Onkoloji Bilim Dalı, Turkey
Title Of Article
Neuroleptic Malignant Syndrome Associated with Metoclopropamide in a Patient with Metastatic Gastric Carcinoma
شماره ركورد
18910
Abstract
Neuroleptic malignant syndrome (NMS) is a rare syndrome which can be fatal and characterized by hyperthermia, muscular rigidity, changes in consciousness, autonomic dysfunction, increased serum creatinine kinase and leukocytosis. We present a case with metastatic gastric cancer developed neuroleptic malignant syndrome after metoclopropamide treatment. Metoclopropamide-associated neuroleptic malignant syndrome is a rare life-threatening condition. It occurs due to blockade of dopamin receptors by metoclopropamid in brain and high cholinergic stimulation.
From Page
53
NaturalLanguageKeyword
Neuroleptic malignant syndrome , metoclopropamide , dopamin receptor blocker
JournalTitle
Gazi Medical Journal
To Page
54
JournalTitle
Gazi Medical Journal
Link To Document